Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in Taiwan

Clinical trial NCT02616380 · COMPLETED

Trial details

NCT number: NCT02616380
Sponsor: AbbVie
Status: COMPLETED
Study type: OBSERVATIONAL

Rheumatoid Arthritis

Start date: 2015-11-05
Primary completion: 2017-11-23
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.